AU2003242860A1 - 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders - Google Patents
2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disordersInfo
- Publication number
- AU2003242860A1 AU2003242860A1 AU2003242860A AU2003242860A AU2003242860A1 AU 2003242860 A1 AU2003242860 A1 AU 2003242860A1 AU 2003242860 A AU2003242860 A AU 2003242860A AU 2003242860 A AU2003242860 A AU 2003242860A AU 2003242860 A1 AU2003242860 A1 AU 2003242860A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- treatment
- proliferative disorders
- cyclin dependent
- dependent kinases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0215775A GB0215775D0 (en) | 2002-07-06 | 2002-07-06 | Pharmaceutical compounds |
| GB0215775.8 | 2002-07-06 | ||
| PCT/GB2003/002905 WO2004004730A2 (en) | 2002-07-06 | 2003-07-04 | 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003242860A8 AU2003242860A8 (en) | 2004-01-23 |
| AU2003242860A1 true AU2003242860A1 (en) | 2004-01-23 |
Family
ID=9940040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003242860A Abandoned AU2003242860A1 (en) | 2002-07-06 | 2003-07-04 | 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003242860A1 (en) |
| GB (1) | GB0215775D0 (en) |
| WO (1) | WO2004004730A2 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2486187C (en) | 2002-05-23 | 2013-02-19 | Cytopia Pty Ltd. | Kinase inhibitors |
| US20080194574A1 (en) * | 2003-12-16 | 2008-08-14 | Axxima Pharmaceuticals Ag | Pyrazine Derivatives As Effective Compounds Against Infectious Diseases |
| US7973061B2 (en) * | 2004-03-31 | 2011-07-05 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
| DE602005019556D1 (en) | 2004-04-13 | 2010-04-08 | Icagen Inc | POLYCYCLIC PYRAZINS AS KALIUMION CHANNEL MODULATORS |
| WO2006044826A2 (en) * | 2004-10-20 | 2006-04-27 | Compass Pharmaceuticals Llc | Thiophens and their use as anti-tumor agents |
| GB0719644D0 (en) * | 2007-10-05 | 2007-11-14 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| DE102008022788A1 (en) * | 2008-05-08 | 2009-11-12 | Süd-Chemie AG | New 2,6-pyrazine bridged transition metal carbene complex useful as a catalyst for oxidation of hydrocarbons |
| WO2010118063A2 (en) * | 2009-04-06 | 2010-10-14 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
| PL2427441T3 (en) | 2009-05-04 | 2017-06-30 | Agios Pharmaceuticals, Inc. | Pkm2 activators for use in the treatment of cancer |
| PL2448581T3 (en) | 2009-06-29 | 2017-06-30 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
| ES2632954T3 (en) | 2009-06-29 | 2017-09-18 | Agios Pharmaceuticals, Inc. | Quinoline-8-sulfonamide derivatives that have an anticancer activity |
| EP2651898B1 (en) | 2010-12-17 | 2015-12-09 | Agios Pharmaceuticals, Inc. | Novel n-(4-(azetidine-1-carbonyl)phenyl)-(hetero-)arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators |
| MX336022B (en) | 2010-12-21 | 2016-01-06 | Agios Pharmaceuticals Inc | Bicyclic pkm2 activators. |
| TWI549947B (en) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | Therapeutic compounds and compositions |
| WO2012151440A1 (en) | 2011-05-03 | 2012-11-08 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia |
| SG194697A1 (en) | 2011-05-03 | 2013-12-30 | Agios Pharmaceuticals Inc | Pyruvate kinase activators for use in therapy |
| WO2014118186A1 (en) | 2013-01-30 | 2014-08-07 | Bayer Pharma Aktiengesellschaft | Amino-substituted isothiazoles |
| WO2014139144A1 (en) | 2013-03-15 | 2014-09-18 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| CN105985322A (en) * | 2015-03-03 | 2016-10-05 | 苏州翔实医药发展有限公司 | Amino pyrazine compound and application thereof |
| US11234976B2 (en) | 2015-06-11 | 2022-02-01 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
| CN112142716B (en) * | 2020-10-29 | 2021-08-31 | 山东新时代药业有限公司 | 5-membered heteroaryl substituted pyrazine derivative and application thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4868183A (en) * | 1986-07-21 | 1989-09-19 | Otsuka Pharmaceutical Factory, Inc. | N-pyrazinyl substituted P-aminophenols |
| GR900100380A (en) * | 1989-05-20 | 1991-10-10 | Fisons Plc | Process for the preparation of anti-inflammatory aminophenol derivatives |
| AU4229999A (en) * | 1998-06-05 | 1999-12-20 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents |
| SE9903894D0 (en) * | 1999-10-28 | 1999-10-28 | New Pharma Research Ab | Novel compounds |
| SE9904108D0 (en) * | 1999-11-15 | 1999-11-15 | New Pharma Research Ab | New compounds |
| CA2423050A1 (en) * | 2000-09-20 | 2002-03-28 | Ortho-Mcneil Pharmaceutical, Inc. | Pyrazine derivatives as modulators of tyrosine kinases |
| IL155702A0 (en) * | 2000-11-20 | 2003-11-23 | Biovitrum Ab | Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5-ht2 receptor |
| US20040102455A1 (en) * | 2001-01-30 | 2004-05-27 | Burns Christopher John | Method of inhibiting kinases |
| CA2463563A1 (en) * | 2001-10-12 | 2003-04-17 | Irm Llc | Kinase inhibitor scaffolds and methods for their preparation |
| GB0124939D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-07-06 GB GB0215775A patent/GB0215775D0/en not_active Ceased
-
2003
- 2003-07-04 WO PCT/GB2003/002905 patent/WO2004004730A2/en not_active Application Discontinuation
- 2003-07-04 AU AU2003242860A patent/AU2003242860A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003242860A8 (en) | 2004-01-23 |
| WO2004004730A3 (en) | 2004-04-29 |
| GB0215775D0 (en) | 2002-08-14 |
| WO2004004730A2 (en) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003242860A1 (en) | 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders | |
| AU2003243318A1 (en) | Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer | |
| AU2003255779A1 (en) | 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors | |
| AU2003223380A1 (en) | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | |
| AU2003206785A1 (en) | Use of tyrosine kinase inhibitors for the treatment of inflammatory processes | |
| EP1511730B8 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
| IL167088A (en) | Pyrazolopyrimidine derivatives as cyclin dependent kinase inhibitors | |
| HK1078858A1 (en) | Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders | |
| AU2003286567A1 (en) | Methods for the treatment of skin disorders | |
| AU2002310187A1 (en) | Inhibitors of protein kinase for the treatment of disease | |
| HK1134486A1 (en) | 4, 5-dihydro- [1, 2, 4] triazolo [4,3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders plk1 45--[124][43- f] | |
| AU2003251559A1 (en) | Heterocyclic inhibitors of kinases | |
| AU2003254053A1 (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
| AU2003254051A1 (en) | Pyrazolopyrimidines as kinase inhibitors | |
| SI1685125T1 (en) | Pyrrole derivatives useful for the treatment of proliferative diseases | |
| PL374401A1 (en) | 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders | |
| AU2003261204A1 (en) | Pyrazolopyrimidines as kinase inhibitors | |
| AU2003290059A1 (en) | Use of cd137 antagonists for the treatment of tumors | |
| AU2003903242A0 (en) | Process for the treatment of wood | |
| AU2002303145A1 (en) | Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases | |
| AU2003233820A1 (en) | Method for the treatment of starch | |
| AU2003223538A1 (en) | Methods for the treatment of cancer | |
| ZA200809016B (en) | 4, 5-Dihydro-[1,2,4] Triazolo [4,3-F] PteridinesS as protein kinase PLK1 inhibitors for the treatment of proliferative disorders | |
| AU2003235951A1 (en) | Process for the preparation of 2-aminopyrazine derivatives | |
| AU2002335027A1 (en) | Treatment of tnf-alpha-mediated disorders with casein kinase i epsilon inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |